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The Dock180 family of atypical Rho family guanine nucleo-
tide exchange factors (Rho-GEFs) regulate a variety of processes
involving cellular or subcellular polarization, including cell
migration and phagocytosis. Each contains a Dock homology
region-1 (DHR-1) domain that is required to localize its GEF
activity to a specific membrane compartment where levels of
phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3) are
up-regulated by the local activity of PtdIns 3-kinase. Here we
define the structural and energetic bases of phosphoinositide
specificity by theDHR-1 domain of Dock1 (a GEF for Rac1), and
show thatDHR-1utilizes aC2domain scaffold and surface loops
to create a basic pocket on its upper surface for recognition of
the PtdIns(3,4,5)P3 head group. The pocket has many of the
characteristics of those observed in pleckstrin homology
domains.We show that pointmutations in the pocket that abol-
ish phospholipid binding in vitro ablate the ability of Dock1 to
induce cell polarization, and propose a model that brings
together recentmechanistic and structural studies to rationalize
the central role ofDHR-1 in dynamicmembrane targeting of the
Rho-GEF activity of Dock180.
The family of Rho-GTPases, including Rac, Cdc42, and
RhoA, localize to specific compartments of the plasma mem-
brane in response to external cues that lead to the modification
of membrane phospholipids (1). Rho-GEFs4 co-localize to the
same membrane locales, where they catalyze the removal of
bound GDP from inactive Rho-GTPases, enabling reloading of
GTP and binding of effector molecules that mediate a variety
of signaling pathways (2). This localized activation controls the
organization and dynamics of the actin cytoskeleton, thereby
regulating a large number of processes involving cell morphol-
ogy, polarity, and migration (3).
Two structurally unrelated families of Rho family GEFs have
been characterized: the “classical” Rho-GEFs (2) and the “atyp-
ical” Dock180 Rho-GEFs (4–6). Dock1 (also called Dock180)
is a GEF for Rac1 (7, 8). It is a large protein (1865 residues) that
includes an N-terminal SH3 domain and flanking helical bun-
dle that mediate formation of a functional complex with the
“engulfment and cell motility” protein, ELMO1 (9–11); a
DHR-1 domain required for targeting to membranes enriched
in PtdIns(3,4,5)P3 (12); and a DHR-2 domain that houses the
GEF activity (4, 6). The structure and novel GEF mechanism of
the Dock9 DHR-2 domain (a GEF for Cdc42) was recently elu-
cidated (13), providing an enzymatic model for the entire Dock
family. Long intervening sequences between the recognized
domains are predicted to be mostly helical, and may fold as
HEAT/ARM repeat domains (2). The C-terminal region
includes (in Dock1 and Dock2) a linear motif that augments
membrane binding (14, 15), and a proline-rich region that
forms a complex with the adaptor protein, CrkII (16).
There are 11 Dock180 members in humans (Dock1–
Dock11), at least two in zebrafish (17), and well characterized
orthologs in Drosophila (“Myoblast City” or “MBC”) (18) and
Caenorhabditis elegans (“ced-5”) (19), which form complexes
with orthologous partners and share many related functions (9,
20). Dock180 proteins have been implicated in a variety of cellular
processes, including cell migration, axonal polarization, tumor
suppression, the engulfment of apoptotic cells, and phagocytosis
of pathogens (9, 12, 21–26). During cell migration, for example,
elevated levels of PtdIns(3,4,5)P3 are created at the leading edge by
the local activity of PtdIns 3-kinase, which promotes membrane
attachment by the Dock1-ELMO complex leading to polarized
activation of Rac1 (4, 5, 8, 12, 27–32).
In all cases tested, the DHR-1 domain has been found neces-
sary for the cellular function of full-length Dock180 family pro-
teins. Here, we report the crystal structure of the DHR-1
domain of Dock1, which comprises a C2 core with several large
insertions, and identify the structural and energetic determi-
nants of phospholipid recognition in vitro and in cells. These
findings, when combined with recent advances by others, lead
us to propose a model for how full-length Dock1 coordinates
membrane specificity conferred by theDHR-1 domainwith the
GEF activity of the DHR-2 domain, which provides a structural
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framework for probing the diverse biological functions medi-
ated by the Dock180 family of GEFs.
EXPERIMENTAL PROCEDURES
Protein Production—The domain boundaries of Dock1
DHR-1 were previously defined (12). The Dock1 DHR-1
domain (422–619) was cloned in pET28a and expressed in
Escherichia coli as a His6-tagged fusion protein. The protein
was purified usingHiTrapNi2-chelating and Superdex 200 gel
filtration columns (GE Healthcare). Protein purity and identity
were confirmed by SDS-PAGE, immunoblot, and matrix-as-
sisted laser desorption ionization time-of-flight mass spec-
trometry. Site-directed mutagenesis was performed using the
QuikChange method (Stratagene) in plasmid pET-28a, and
confirmed by DNA sequencing. Mutant proteins were ex-
pressed and purified as for wild-type, and melting temperature
profiles were determined using a CSC Nano II Differential
Scanning Calorimeter.
Isothermal Titration Calorimetry (ITC)—Experiments were
carried out on a Microcal VP ITC200 isothermal titration cal-
orimeter from Microcal (Northampton, MA). Each titration
involved 19 injections of 2-l aliquots of1 mM water-soluble
di-C8 phosphoinositide analogs (Echelon Biosciences, Salt
LakeCity, UT) or InsP4 into cells containing 25–100MDHR-1
at 23 °C. Buffers were comprised of 10 mM Tris-HCl, pH 8.0, 2
mM-mercaptoethanol, and either 14 or 145mMNaCl. Folding
and monodispersity of DHR-1 were confirmed by size exclu-
sion chromatography and differential scanning calorimetry. To
account for heat changes associated with dilution of the phos-
phoinositide analogs, control titrations into buffer were
employed. The use of di-C8 phosphoinositide stock solutions at
1 mM concentration avoids complications arising from
micelle formation (critical micellar concentration 5 mM). By
lowering the NaCl concentration to 15 mM, the enthalpy
change increased by4-fold, and reproducible binding curves
that achieved full saturation were obtained for wild-type and
mutant proteins. For the competition assays, a 1.5 M excess of
either the PtdIns(3,4,5)P3 or PtdIns(4,5)P2 analogs was first
incubated with DHR-1 in the ITC cell, prior to titration of the
other phospholipid. For Ca2 binding experiments, aliquots of
4.0 or 8.0 mM CaCl2 were injected into cells containing 200 or
400 M DHR-1 (which had previously been dialyzed in 2 mM
EGTA). No binding was observed (data not shown). Thermo-
dynamic parameters were obtained using the Origin 7 software
package (Microcal).
Crystallization and Data Collection—DHR-1 crystals were
grown at 293Kusing themicrobatchmethodunder oil. 1.5l of
solution containing 5.5 mg/ml of DHR-1 in 12.5 mM Tris-HCl,
pH 8.8, 75 mM NaCl, 2.5 mM -mercaptoethanol, was mixed
with 3 l of reservoir containing 30% (w/v) polyethylene glycol
10K, 0.2M sodiumacetate, 0.1MTris-HCl, pH8.8. Crystals grew
asmonoclinic plates within 2–3 weeks, and were flash frozen in
liquid nitrogen after briefly rinsing in paratone-N oil. Diffrac-
tion data were collected at the Stanford Synchrotron Radiation
Laboratory beamline 9-2 at a wavelength of 0.912 Å, and
recorded with a Mar325 CCD detector controlled by BLU-ICE
(33). Data were integrated, scaled, and reduced using HKL2000
(34) (see Table 1).
Structure Determination—Initial molecular replacement
efforts were unsuccessful, as were efforts to incorporate con-
ventional heavy atoms or selenomethionine. Consequently, a
more extensive molecular replacement search strategy was
pursued using the search pipeline (35) based onMOLREP (36),
with automated parameter-space screening. The search
employed models derived from the distant homology se-
quence-recognition algorithm (37). The top solution was the
RIM2 C2A domain (PDB code 2BWQ), which has 10%
sequence identity over 50%of theDHR-1 domain. This solution
was independently confirmed using PHASER (38), and further
optimized in a second round of parallelized searches with a
large set of trimmed RIM2 C2A polyalanine models generated
by combinatorial removal of loops, regions of neighboring gaps
in the model, and regions of lowest sequence similarity. Initial
phases allowed a partial model to be built. Phase combination,
iterative model building, and refinement with Coot (39),
REFMAC5 (40), and CNS (41), using  A-weighted composite
omit maps and 2Fo Fcmaps, allowed most of the model to be
built. The asymmetric unit includes two DHR-1 domains, 81
water molecules, and a modified residue (the -mercaptoetha-
nol adduct of C595) in each domain. Electron density was not
observed for the His tag, the N terminus (422–424 in both
copies), or the C terminus (610/612–619), or for a surface loop
within the 7–8 subdomain (580/581–587). The L1 and L3
loops have relatively weak density, but distinct conformations
are evident for molecules A and B (supplemental Fig. S1). The
rootmean square deviation between backbone atoms of the two
molecules in the asymmetric unit is 0.54 Å (for 161 equivalent
residues). Stereochemical quality of the final model was
assessed using AutoDepInputTool (42), MolProbity (43),
SFcheck 4.0 (44), and WHATIF 5.0 (45). 97.2 and 99.8% of the
main chain torsion angles are in the favored and allowed
regions, respectively. Data collection and refinement statistics
are summarized in Table 1.
Molecular Docking and Modeling of Full-length Dock1—
Docking simulations were performed with Molegro Virtual
Docker (46) using di-C2 PtdIns(3,4,5)P3 or its head group, ino-
sitol 1,3,4,5-tetraphosphate (InsP4). The docking runs included
a maximum of 1500 iterations with a population size of 50 and
a minimum of 10 runs. Binding modes were analyzed using the
“re-ranking score.” Docking solutions from the initial runs,
with no search space constraints and default parameters, were
clustered at two sites. In the subsequent docking simulations,
side chain flexibility was introduced, and the search space
radius was set to 20 or 15 Å from the centers of the binding
cavities. Distance restraints penalized the interaction between
the aliphatic carbon atoms di-C2 PtdIns(3,4,5)P3 and the pro-
tein. The “MolDock [GRID]” scoring function and “Tabu pose”
clustering algorithms were used for side chain flexible docking
simulations. Side chain torsional angles allowed to vary during
simulation were: on the upper surface, Lys439, Ser441, Lys442,
Thr443, Thr444, Lys446, Asn447, Tyr484, Gln485, His515, Gln519,
Asp523, Lys524, Phe529, and Lys555; and in the -groove, Glu449,
Thr451, Ser453, Tyr455, Arg461, Glu477, Lys479, Arg510, Arg514,
Arg516, Lys527, Ile528, Glu562, and Asp600.
For modeling full-length Dock1, dimeric DHR-2/Rac1 and
ARM-repeat Dock1 models were based on the crystal struc-
Dock180 DHR-1Membrane Binding
13212 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 17•APRIL 23, 2010
 at UQ Library on October 6, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
tures of Dock9 DHR-2/Cdc42 (PDB code 2WM9) (13) and
importin- (PDB code 2QNA) (47). Homology models were
built using SCWRL4 (48) and Phyre (49). The ARM-DHR-2
interaction interface was determined using the RosettaDock
docking algorithm (50).
Cell Culture, Transfection, and Cell Spreading Assays—CHO
LR73 cells were grown in Dulbecco’s modified Eagle’s medium
containing 10% fetal bovine serum and penicillin-streptomycin
antibiotics, and assayed as previously described (11, 12). Briefly,
cells were transfected with the indi-
cated plasmids. Cells were starved
overnight in 0.1% serum medium,
then allowed to spread on fibronec-
tin, and stained for Dock1, actin,
and cell nuclei. Anti-Dock1 (H-4
and H-70) and anti-Myc (9E10)
antibodies were obtained from
Santa Cruz Biotechnologies.
RESULTS
Crystal Structure of the Dock1
DHR-1 Domain—We expressed a
construct of Dock1 in E. coli com-
prising residues 422–619, which is
the minimal fragment that main-
tains specific PtdIns(3,4,5)P3 bind-
ing activity (12) (Fig. 1A). We deter-
mined its crystal structure at 2.37-Å
resolution (Table 1, Figs. 1 and 2)
using automatedmolecular replace-
ment searches and phase recombi-
nation (see “Experimental Proce-
dures” and Table 1). The central
core of the structure adopts an anti-
parallel -sandwich with the “type
II” C2 domain fold (a circular per-
mutation of the more common
“type I” topology (51, 52)), in which
two 4-stranded sheets with strand
orders 6-5-2-3 and 7-8-1-4 create
convex- and concave-exposed faces,
respectively. Structural compari-
sons using DALI (53) show that the
-sandwich core is similar to at least
38 C2 domains (of either topology)
in the PDB with root mean square
deviations between 1.7 and 3.6 Å for
101–143 C atoms, but very low
identities in all cases: 7–16% (sup-
plemental Fig. S2). Elaborations to
the core include three loops (1–
2 L1;3–4 L2; and5–6
L3) on the upper surface, as well as
two further large insertions (see
below) that may explain why
sequence alignment algorithms had
difficulty in recognizing the C2-fold
(12). The most extensive structural
similarity occurs with the C2 domain of PtdIns 3-kinase
(supplemental Fig. S3; root mean square difference 2.8 Å for
143 Cs; 10% identity), which, intriguingly, is the enzyme that
generates PtdIns(3,4,5)P3 at the leading edge of migrating cells.
The crystals contain two independent copies of the DHR-1
domain (molecules “A” and “B”), which are very similar except
for the conformations of the large loops (L1 and L3) on the
upper surface of the domain (supplemental Fig. S3). In Mole-
cule A, which is free from lattice contacts in the loop region, a
FIGURE 1. Structure of the Dock1 DHR-1 domain. A, domain organization of Dock1, with residue limits and
major binding partners indicated. ELMO1 binds to a module comprising the SH3 domains and “EB” helical
segment, as well as segments at the C terminus (not shown) (11, 85). ARM, Armadillo/HEAT repeat; EB, ELMO-
binding; PL, phospholipid; Crk, CrkII. B, stereo C plot of DHR-1 (cyan) overlaid with the C2 domain of PtdIns
3-kinase- (red). The latter is disordered at loop L3 and has shorter 2–3 and 7–8 insertions. DHR-1 is
disordered between residues 579 and 588. Strands and loops are numbered, and termini labeled. C, schematic
of DHR-1 in the same view as in B. The -sandwich core (with strands numbered) is in green, insertions in blue.
D, surface charge potential (83) on DHR-1. The view is rotated 90° about a vertical axis to show the basic
surfaces, with computational docking solutions (see text) for the PtdIns(3,4,5)P3 head group in the upper
surface pocket and -groove (note that there is no experimental evidence for binding in the -groove).
Dock180 DHR-1Membrane Binding
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cluster of lysines points inward, whereas acidic residues point
outward, creating a positively charged pocket at the top of the
molecule. In Molecule B, a major lattice contact appears to
trigger or stabilize a distinct organization of the loops in which
the charged residues create a network of salt bridges, and the
positively charged pocket seen in Molecule A is not observed.
The absence of crystal contacts, as well as mutagenesis and
modeling studies (see below), are fully consistentwithMolecule
A representing the functional conformation in solution. More-
over, we found that a point mutant (D436Y) that disrupts a salt
bridge observed only inMolecule Bhadno functional effect (see
below). Molecule A was therefore used for all modeling and
structural analysis.
Insertions into the C2 Core—In addition to the 3 surface
loops, there are 2 major elaborations of the C2 core: a 20-resi-
due insertion (457–476) between 2 and 3 on one side of the
sandwich; and a 42-residue (557–598) subdomain inserted
between 7 and 8 that packs against the opposite side (Figs. 1
and 2). The 2–3 insertion first forms a ridge along the bot-
tom of the 6-5-2-3 sheet; it then crosses over to the 7-8-1-4
sheet, forming a short strand (3A) that augments the4 end of
the sheet and provides two hydrophobic side chains (Val465 and
Ile466) that insert into and seal this edge of the sandwich, before
returning to the C2 core via a well defined loop that is unique to
DHR-1. 3 is irregular at its C-terminal end, where it adopts
cross-sheet interactions with the side chains of Glu493 and the
buried Trp491.
The7–8 insertion forms a subdomain at the opposite edge
of the-sandwich, beginningwith an extension of the7 strand
(7) that crosses over to the other sheet, forming main chain
hydrogen bonds with the beginning of 6, and inserting two
side chains (Leu551 and Val553) between the sheets, sealing this
edge of the sandwich (the two cross-over strands, 7 and 3A,
effectively create a -barrel). The subdomain next adopts two
short helical elements (H2/H3) that form a ridge along the left
side of the concave face, which connects with the 2–3 inser-
tion at the bottom, and a bulge formed by the start and end of
L3, to create a continuous ridge and a distinctive pocket on the
concave face, which is highly basic (Fig. 1D). Many C2 domains
have a pocket here, which is often called the “-groove” (54). A
third helical segment (H4) extends away from the body of the
domain, followed by a disordered loop (residues 581 and 587)
and a -hairpin, before finally returning to the C2 core via the
8 strand.Thehairpin includes a partly buried cysteine (Cys595)
that forms a stable adduct with -mercaptoethanol in the crys-
tals; however, we found no evidence that the cysteine plays a
functional role, because a C595A mutant behaved like wild-
type in phospholipid binding and cell-based assays (see below).
DHR-1 Binds Short Chain Analogs of PtdIns(3,4,5)P3 and
PtdIns(4,5)P2 atOverlapping Sites—Weexplored the specificity
of phospholipid binding in solution by using monodisperse
phosphoinositide analogs and ITC, which allows precise deter-
mination of binding constants and thermodynamic parameters
(Figs. 3 and supplemental S4). We first defined conditions for
the reproducible binding of DHR-1 to di-C8-PtdIns(3,4,5)P3.
Although we could observe 1:1 binding in 145 mM NaCl, the
affinity (Kd  32  6 M) was close to the technical limits of
detection, given the need to limit the lipid concentration to
avoid micelle formation. To enhance detection, we shifted to a
lower ionic strength (20 mM), which increased the binding
affinity 10-fold (Kd 3.0 0.9 M) without changing the stoi-
chiometry (Fig. 3B). These conditions allowed us to study the
effects of mutations and compare the binding of other phos-
pholipids. We found that Ins(1,3,4,5)P4 (the PtdIns(3,4,5)P3
head group) bound with a comparable affinity (Kd 7.7 3.0
M) and stoichiometry, consistent with a dominant role for
ionic interactions between a positively charged protein surface
and the negatively charged phosphate groups. In both cases,
binding was largely enthalpy-driven.
Because many C2 domains have a broad specificity for ani-
onic lipids, we explored the binding of PtdIns mono- and
bisphosphates. No binding was observed by titrating with
PtdIns(3)P1, PtdIns(3,4)P2, or PtdIns(3,5)P2. However, we
found that PtdIns(4,5)P2 bound reproducibly, with a Kd similar
to that of PtdIns(3,4,5)P3 and a stoichiometry approaching 1:1.
However, in this case, binding was largely entropy-driven, with
only a small enthalpic contribution (Fig. 3B). To determine
whether PtdIns(3,4,5)P3 and PtdIns(4,5)P2 bound at overlap-
ping or distinct sites, we used a competition assay in which
DHR-1 was first preincubated with an excess of one lipid and
titrated with the other. Given the similar binding free energies
but different enthalpic contributions, if binding is reversible
and competitive, then titration of PtdIns(3,4,5)P3 into DHR-1/
PtdIns(4,5)P2 should displace PtdIns(4,5)P2 in an exothermic
reaction, whereas titration of PtdIns(4,5)P2 into DHR-1/
PtdIns(3,4,5)P3 should be endothermic; and this was indeed the
case (Fig. 3, E and F).
TABLE 1
Crystallographic analysis andmodel refinement
Space group P21
Unit cell parameters a 47.0Å, b 63.5Å,
c 63.4Å,  109.3°
Wavelength (Å) 0.9116
Resolution range (Å) 50–2.37
Number of observations 53,672
Completeness (%) 99.4 (97.5)a
Mean I/(I) 22.6 (6.9)a
RSYM on Ib 0.076 (0.216)a
Outer resolution shell (Å) 2.45-2.37
Model and refinement statistics
Resolution range (Å) 50–2.37
Protein residues (all atoms) 349 (2,926)
Average B-factor (Å2) 44.0
Unique reflections (test set) 13,960 (679)
Rwork (%)c 21.6
Rfree (%)d 26.8
Stereochemical parameters
Observed rms deviations from
ideality
Bond lengths (Å) 0.006
Bond angles (°) 1.43
Torsion angles (°) 25.34
Improper torsion angles (°) 0.74
Ramachandran outliersb 0.3%
Estimated coordinate error
Low resolution cut-off (Å) 5.0
Luzzati coordinate error (Å) 0.29
 A coordinate error (Å) 0.24
aOuter resolution shell in parentheses.
bRSYMIi Ii	/Ii, where Ii is the scaled intensity of the ith measurement and
Ii	 is the mean intensity for that reflection.
c Rwork Fo Fc/Fo, where Fc and Fo are the calculated and observed struc-
ture factor amplitudes, respectively.
dRfree is the same as Rwork, but calculated on the 5% of reflections that were omitted
from refinement.
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Phosphoinositide Binding Is Mediated by the Upper Loops of
DHR-1, Not the -Groove—Most C2 domains that engage
membrane do so in a Ca2-mediated fashion via a cluster of
acidic residues on their surface loops (supplemental Fig. S5)
(52, 54, 55), whereas a subset utilize a positively charged -
groove (56–58) (see Figs. 1D and supplemental S6). Ca2-inde-
pendent binding via the upper loops is far less common, and
those that do bind phosphoinositide in this way typically show
little specificity (59). The DHR-1 C2 domain displays regions of
broad positive potential both in the-groove and on the surface
loops (see Figs. 1D and supplemental S6), and we confirmed
that DHR-1 does not bind Ca2 by calorimetry (data not
shown). Both regions are thus candidates for binding negatively
charged lipids in a Ca2-independent fashion. As an objective
first step, we employed computational docking using theMole-
gro Virtual Docker (46), which allows for ligand and protein
side chain flexibility, to search for phospholipid binding sites.
Using Ins(1,3,4,5)P4 as the ligand, this procedure generated two
clusters of docking solutions in the expected regions (see Figs.
1D and supplemental S6). The first cluster, on the upper sur-
face, occurs where a pocket is formed by basic and polar resi-
dues from all three loops, and includes a histidine, tyrosine, and
four lysines. The second cluster is in the -groove, which con-
tains a similar arrangement of basic and aromatic side chains.
In a previous study, DHR-1 with six lysines simultaneously
mutated to alanine failed to bind PtdIns(3,4,5)P3 in a bead pull-
down assay (12). Our crystal structure shows that 4 of these
lysines (Lys439, Lys442, Lys446, and Lys524) line the pocket on the
upper surface, one (Lys527) forms part of the -groove, and one
(Lys522) is in neither pocket (Fig. 3D). Although this mutant is
consistent with our docking studies, it does not delineate the
roles of the two pockets; moreover, its fold-integrity was not
demonstrated.We therefore generated single site mutants, and
determined their melting temperatures using differential scan-
ning calorimetry, which provides a sensitivemeasure of tertiary
fold-integrity. We first made Lys3 Ala mutants of each of the
FIGURE2.SequencesofDock180 familyDHR-1domains.A,domainorganizationof the4groupsofhuman full-lengthproteins.B, structure-basedalignment
of the 11 humanDHR-1 sequences andDrosophilamyoblast city, which belongs to theDockA group. The secondary structure is indicated. The 3 surface loops,
L1–L3, are indicated by red boxes; they are delimited by conserved residues marked by black arrows. Residues predicted to contact phospholipid in Dock1
DHR-1 aremarkedwith a red asterisk; those supported bymutagenesis are boxed in blue. Contact residues in other familymembers predicted by homology are
shown in blue (H/K/R) or red (others). Conserved structural residues are in black (bold). Residuesmutated in this study that do not affect phospholipid binding
are highlighted in yellow; 3 of these are on L3 but point into the -groove. The 2 large insertions in the C2 core are also indicated.
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4 lysines in the upper pocket (Lys439, Lys442, Lys446 (L1), and
Lys524 (L3)), none ofwhich form salt bridges or hydrogen bonds
in the wild-type structure. All 4 mutants folded well, as judged
by melting temperatures, Tm (Fig. 3C), and reproducible bind-
ing data were collected by ITC in each case. We found that the
K524A mutation reduced PtdIns(3,4,5)P3 binding 2-fold,
whereas mutation of any one of the 3 L1 lysines completely
abolished binding (Fig. 3C).
We next made point mutants in the -groove, and were able
to collect reliable data from 3 of them (R514A, R516A, and
K527A). Note that these residues lie on L3, but that their side
chains point away from the surface pocket. In contrast to the
surface pocket mutants, none of these mutants significantly
affected PtdIns(3,4,5)P3 binding (Fig. 3C). Other mutants in
this region, including K479A and
K479Q, folded either with reduced
stability (
Tm 5 °C) or, in the case
of R510A, not at all, presumably
because these residues play impor-
tant structural roles. Thus, Arg510,
which lies at the heart of the
-groove, is partly buried, making
several intramolecular hydrogen
bonds; whereas Lys479 makes inter-
strand salt bridges and hydrogen
bonds.
We also tested binding of the L1
mutants, K442A and K446A, to
PtdIns(4,5)P2, and found, as for
PtdIns(3,4,5)P3, that binding was
completely abolished in both cases
(data not shown). Taken together,
our studies suggest that DHR-1
has a high level of specificity for
PtdIns(3,4,5)P3 and PtdIns(4,5)P2,
which bind competitively to the
same or overlapping sites within the
pocket on the upper surface. More-
over, we conclude that the -groove
plays no role in binding to these or
any of the phospholipids tested.
Point Mutants That Ablate Phos-
pholipid Binding in Vitro Inhibit
Cellular Polarization—We next
constructed 3 full-length Dock1
point mutants with Lys 3 Ala
mutations in the L1 lysines, and
tested their function in a cell-based
assay. We used the assay previously
established (11, 12) in which
co-transfection of Dock1/ELMO1/
CrkII into LR73 cells triggers cell
elongation in a PI 3-kinase-depen-
dent fashion when cells are replated
on fibronectin (a measure of the
polarizability of spreading cells,
which correlates with cell migra-
tion). We found that all 3 mutants
caused a consistent reduction in cell elongation, as well as an
increase in cell rounding (Fig. 4), indistinguishable from the
effects seen previously for Dock1 with the entire DHR-1
domain deleted (12). Thus, point mutations in DHR-1 that
ablate the binding of PtdIns(3,4,5)P3 in vitromanifest as a loss-
of-function of the full-length molecule in this cell-based assay.
A Model for Phospholipid Binding to the Dock1 DHR1
Domain—We were not able to co-crystallize the DHR-1
domain with PtdIns(3,4,5)P3 or Ins(1,3,4,5)P3, and indeed no
experimental structures of inositol phosphates bound to Type
II C2 domains have been determined, presumably because of
their weak affinities and/or nonspecific binding. By contrast,
many signaling molecules contain PH domains that bind inosi-
tol phosphates with high affinity, and many structures have
FIGURE 3. Phosphoinositide binding to the DHR-1 domain. A, the head group of PtdIns(3,4,5)P3 with phos-
phate positions numbered. B, thermodynamic parameters for phosphoinositide and head group binding to
wild-type DHR-1 (Kd, dissociation constant;
H, enthalpy change; T
S, temperature (K) entropy change;
G
(the free energy change)
H-T
SRT ln Kd);N is the apparent stoichiometry. Nobindingwas observed for
PtdIns(3,5)P2, PtdIns(3,4)P2, or PtdIns(3)P1. * indicates the experimentwas performed in 145mMNaCl. All other
experiments were carried out in low salt (see “Experimental Procedures”). Representative ITC profiles are
provided in supplemental Fig. S4. C, effect of point mutations on PtdIns(3,4,5)P3 binding, defined as Kd(wt)/
Kd(mutant). Error estimates are from fitting of ITC titration curves. At right are melting temperatures, Tm, for
each mutant, in °C. *, the Tm value given for K524A is actually for the triple mutant, K446A/K524A/K555A.
D, mutation sites mapped onto the DHR-1 structure. E and F, ITC competition titrations (negative values of
energy indicate an exothermic reaction; positive values, endothermic). E, DHR-1 equilibrated with a 1.5 M
excess of PtdIns(4,5)P2 titratedwith PtdIns(3,4,5)P3. F, the converse experiment: DHR-1/PtdIns(3,4,5)P3 titrated
with PtdIns(4,5)P2.
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been determined. For example, the PH domain of a splice var-
iant of ARNO (60) displays many characteristics of the DHR-1
binding site: thus, the pockets have a strikingly similar shape
and character, including a tyrosine and histidine in addition to
a cluster of Arg/Lys; and both accommodate 2 of the 3 phos-
phate moieties of PtdIns(3,4,5)P3 buried deep within the
pocket, with the 3rd phosphate more surface exposed (Fig. 5).
Although atomic details must remain speculative in the
absence of direct structural data, themodel presented in Fig. 5A
is fully consistentwith the phospholipid binding preferenceswe
observed. Thus, the 4- and 5-phosphate moieties are buried in
two basic subpockets, forming strong ionic interactions. The
3-phosphate can make hydrogen bonds to the polar residues,
Tyr484 and Gln519, but these surface-exposed bonds are
likely to contribute much less energetically. The lack of a
3-phosphate on PtdIns(4,5)P2, assuming it binds in the same
orientation, would therefore rationalize the similar affinities
of PtdIns(4,5)P2 and PtdIns(3,4,5)P3. And in the case of
PtdIns(3,4)P2, PtdIns(3,5)P2, or PtdIns(3)P1, only one of the
high affinity subsites could be occupied, consistent with the
lack of binding observed in these cases.
Implications for the Dock180 Family—The 11 human
DOCK180 paralogs have been divided into four classes, A–D,
based on overall sequence identity and domain organization
(4–6) (see Fig. 2). Classes A/B and C/D form distinct groups
with higher levels of structural and functional similarity.
Sequence alignments and secondary structure predictions, as
well as three-dimensional homologymodeling (not shown), are
consistent with theDHR1 domains of all Dock180 familymem-
bers adopting a similar fold with a C2 core. The most obvious
differences between them are the lengths of two of the phos-
pholipid-binding loops (L1 and L3) and the 7–8 subdomain,
which is mostly conserved in the A/B group, but significantly
shorter in classes C and D.
Mapping sequence conservation among the A/B group onto
the surface of the domain reveals, in addition to the phospho-
lipid binding region, two further surfaces with a high level of
conservation, raising the possibility that they are also involved
in intra- or intermolecular interactions (Fig. 6). One conserved
surface occurs along an edge (3–4) of the -sandwich, and
includes the2–3 inserted loop (Fig. 6A). There is a precedent
for a C2 domain utilizing this edge of the sheet for protein-
protein interactions: via recognition of a phosphotyrosine in
the target protein that inserts between the sheets (61). One
possibility, which is consistent with our model of full-length
Dock1 (see below) and supported by experiments with Dock9
(62), is that this surface interacts with either (or both) DHR2
and Rac1. The second conserved region encompasses the lower
surface of the DHR-1 domain (Fig. 6C). In the structure of
PtdIns 3-kinase, the lower surface of its C2 domain packs
against an ARM-repeat scaffold; given the extended struc-
tural similarity in their C2 domains and the prediction of
FIGURE 4. Point mutations in the DHR-1 domain inhibit cell elongation
by Dock1. A, cells transfected with plasmids expressing wild-type or
mutant Dock1, together with plasmids for ELMO1 and CrkII, were detached and
platedon fibronectin-coatedchambers for 2h, and stainedwithanti-Dock1anti-
body, rhodamine, phalloidin, and 4,6-diamidino-2-phenylindole (photographed
at 100 magnification: scale bar, 10 m). B, quantification of cell behavior.
Independent fields were photographed at lower magnification, and scored
for three phenotypes: round, spread, and elongated. Data in A and B are
representative of three independent experiments. C, expression levels of
transfected proteins analyzed by immunoblotting cell lysates.
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ARM-repeats in Dock1 (see below), it is possible that DHR-1
makes a similar interaction (supplemental Fig. S3). For
classes C and D, surface conservation is class-specific, and
the features conserved throughout the family are elements of
the phospholipid binding site and the edge of the -sand-
wich (not shown).
Phopholipid Binding by the Dock180 Family—The 6 residues
delimiting loops L1–L3 pack against each other as well as their
counterparts on the adjacent loop(s), forming an aromatic/hy-
drophobic “quilt” that seals the top of the -sandwich, and
which is highly conserved throughout the Dock180 family.
These residues provide reference points for discussing phos-
pholipid binding (see Figs. 2 and supplemental S7).
In group A/B, the L1 loop comprises the motif 437FXBXX-
BXXXBNV448 (where B K/R; phospholipid-binding residues
in bold; Dock1 numbering). Classes C and D diverge in
length and sequence of L1, although they all contain the
BNV motif (Asn446 plays a structural role, cross-linking the
bases of the three loops) at the end of L1, as well as 1 or 2
further basic residues that can be modeled to interact with
phospholipid. The L2 loop is invariant in length in all 4
classes, with a conserved sequence 463VXYQ/HXXXP470 in
which the YQ/H pair (HH in class D) are predicted to form
the “3-phosphate” end of the binding pocket. The L3 loops
are the most divergent in terms of length and sequence, and
are class-specific. They are delimited by Phe513 and Phe/
Val529, and include the invariant His515, which lies at the base
of the binding pocket. An alternating pattern of basic residues,
consistent with an extended loop, is also discernible in each
case (supplemental Fig. S7), and can be modeled to interact
with the phospholipid head group.
It therefore seems very likely that all DHR-1 domains will
recognize phospholipids using similar motifs, and the available
experimental data support this conjecture. Thus,Dock1,Dock2
and Drosophila myoblast city (Class A), and Dock4 (Class B),
bind PtdIns(3,4,5)P3 in vitro and function in a PI 3-kinase-de-
pendent fashion (12, 28, 29, 32). For Class C, although direct
binding in vitro has not been tested, the function of at least one
member, Dock7, is mediated by Rac activation and dependent
on PtdIns 3-kinase activity (63).
FIGURE 5. The PtdIns(3,4,5)P3 binding pocket in DHR-1 and comparison with ARNO. A, stereo image of the PtdIns(3,4,5)P3 head group docked into the
upper surface pocket of the DHR-1 domain, with a zoom-in to show residues predicted to form the pocket and/or bind phospholipid. B, same view as the
zoom-in with the binding pocket shown as electrostatic surface. C and D, ARNO PH domain and its complex with Ins(1,3,4,5)P4 (PDB code 1U27) (60), with
the pocket oriented to show surface similarity.
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For Class D, an additional factor is the presence of a PH
domain that may also contribute to membrane targeting. The
only lipid binding study, on Dock9, showed that the PH
domain bound phosphatidylinositol monophosphates and
PtdIns(3,5)P2, as well as PtdSer in vitro (64). The solution struc-
ture of the Dock9 PH domain (PDB code 1WG7) is consistent
with these binding data, because its canonical phospholipid
binding site displays a basic but shallow pocket suitable for
engaging a single phosphate (11) (supplemental Fig. S8); and a
tyrosine, conserved in PH domains that engage a 4-phosphate,
is replaced by a phenylalanine in Dock9 (65). Although the
isolated DHR-1 domain was not studied, full-length Dock9
showed additional preferences for PtdIns(3,4)P2, PtdIns(4,5)P2,
and PtdIns(3,4,5)P3, which are at least consistent with a DHR-1
specificity similar to other Dock180 family members; however,
further experiments are clearly needed here.
DHR-1 Mutations and Disease—Two mutations in the
DHR-1 domain have been linked to disease. A spontaneous
9-residue deletion in Dock5, Asp488–Asp496 (Dock1 number-
ing), causes “rupture of lens cataract” in mice (86). Our crystal
structure shows that this deletion removes most of strand 4,
which immediately follows the L2 residues forming the back of
the phospholipid binding pocket. The deletion is therefore pre-
dicted to disrupt phospholipid binding (and very likely compro-
mises folding of the entire domain). Our experiments therefore
point to this mutant losing its membrane targeting ability and
thus, whereas it may retain GEF activity in vitro, will be dys-
functional in cells.
Several Dock180 familymembers have been linked to tumor-
igenesis (66), and screening to identify somatically acquired
epigenetic mutations in human cancers identified the point
mutation, D436Y, within Dock1 DHR-1. Asp436 is conserved in
the DockA/B subfamily, surface-exposed, and adjacent to the
PtdIns(3,4,5)P3-binding pocket (Fig. 2D). We constructed the
DHR-1 D436Y mutant and determined that its fold-integrity
was not compromised, and that it bound PtdIns(3,4,5)P3 with
wild-type affinity (Kd 3.4 M).We conclude that if the muta-
tion is linked to tumorigenesis, then it must affect a distinct
inter- or intra-molecular interaction.
DISCUSSION
We have shown that a basic pocket on the upper surface
of the DHR-1 domain mediates binding to the head group of
PtdIns(3,4,5)P3 in vitro, and that point mutations in any one of
three lysines lining this pocket ablate the ability of full-length
Dock1 to induce cell elongation (in the context of its binding
partners, ELMO and CrkII). Our observation of specific bind-
ing of DHR-1 to PtdIns(3,4,5)P3 is consistent with previous
qualitative studies in vitro using different methodologies, as
well as pulldown of Dock1 from cell lysates, and the PI 3-kinase
dependence of Dock1 function in cells (12). This level of phos-
pholipid specificity is unusual for a Type II C2 domain (54), but
our structural and modeling studies suggest how this is
achieved, through the creation of a pocket that closely resem-
bles those found in PH domains, albeit in a distinct structural
context (Fig. 4, B and D).
Our observation that DHR-1 also binds to (short chain)
PtdIns(4,5)P2 was more surprising, but consistent with our
modeling studies as well as a recent proteomics study, in which
Dock1 was isolated from cytosolic extracts by interacting spe-
cifically with liposomes containing PtdIns(4,5)P2 (but not
PtdIns(3,5)P2) (67). However, in another study, employing
phospholipid-coated beads, stronger binding to DHR-1 was
observed with PtdIns(3,5)P2 than with PtdIns(4,5)P2 (12). Dif-
ferences of this kind are not unexpected (68), and presumably
arise from the distinct experimental approaches, each of which
presents the phospholipid in a different context (and none of
which is likely to recapitulate conditions in vivo, for which the
components and dynamics of intracellular lipid microdomains
have not been defined).
Membrane Localization by Dock1—How does the DHR-1
domain localize Dock1 to PtdIns(3,4,5)P3-enriched mem-
branes, and how does it control the GEF activity of DHR-2?
First, it should be noted that overexpression of Dock1 lacking
the DHR-1 domain leads to efficient GTP loading of Rac1 (12),
and does not require ELMO1 (11). However, both elements are
FIGURE 6. Surface conservation of Dock180 proteins. Sequence conserva-
tion within the DockA/B group (green, conserved; purple, variable) of DHR-1
mapped onto Dock1 DHR-1. 3 views are shown and compared with the elec-
trostatic surface potential. A is a view along the edge of the-sandwich; B is a
side view showing the -groove; and C is a top view looking down onto the
upper surface, with InsP4 docked into the upper surface binding pocket.
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required for cellular processes that require local, polarized acti-
vation of Rac1, such as cell migration, where Rac1 activation at
the leading edge, and rapid assembly and disassembly of activa-
tion complexes, drive dynamic cycles of elongation, spreading,
and retraction.
The low membrane affinity of the DHR-1 domain is a com-
mon feature of signalingmolecules, one that may allow them to
rapidly sample the membrane until they reach their optimal
location (69, 70). In the case of DHR-1, a significant affinity for
the abundant lipid, PtdIns(4,5)P2, as we observed in vitro, could
provide a pathway to more rapidly locate the much rarer
PtdIns(3,4,5)P3 (71).Once located, it has been shown in the case
of another signaling protein, GAP1 (which also binds
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 with a similar affinity in
vitro), that a subtle (2-fold) increase in retention time at the
membrane (caused by a reduced off-rate) is sufficient for an
effective functional response to the activation of PtdIns 3-ki-
nase (70).
Given the relatively weak affinity of DHR-1 for phospholip-
ids, it may seem remarkable that point mutations in the DHR-1
domain (which do not compromise fold integrity) can have
such a profound functional effect. However, specific lipid rec-
ognition is typically only one element of membrane targeting.
In a process of combinatorial signal integration that has also
been called “coincidence detection” (72, 73), there is abundant
evidence that simultaneous engagement of a second ligand (e.g.
a protein or another lipid) that independently localizes to the
same site provides a combinatorial signal that defines (and
refines) the optimal membrane location. In the context of such
a combinatorial binding/spatial coincidence event, weak but
specificmembrane binding of theDHR-1 domain (or any one of
the contributors) would be sufficient to tip the balance between
assembly and disassembly of the membrane-targeted GEF
complex.We previously proposed a relatedmodel for the com-
binatorial/coincidence activation of vinculin at cell-matrix
adhesions (74), which was corroborated by subsequent experi-
ments (75).
Thus, in the case of Dock2, a linear C-terminal motif that
recognizes phosphatidic acid has been shown to be necessary
for correct membrane localization in leukocytes (15); and an
analogousmotif inDock1 (14), or the PHdomain ofDock9 (64),
could provide a similar “coincidence” signal. Moreover, Dock1
forms a near-constitutive complex with ELMO1, which binds
to several proteins, including RhoG, Bai1, and ERM, that inde-
pendently localize to PtdIns(3,4,5)P3-enriched membranes
(76–80). Finally, the target of Dock1, Rac1, localizes to the
same sites via a basic motif at its C terminus (81), and the
DHR-2 domain has significant affinity for its target (the GDP-
bound form).
A Three-dimensional Model for Dock180—The above con-
siderations suggest that the system is finely poised, energeti-
cally and dynamically, which would require that there is a close
structural and functional linkage between the DHR-1 and
DHR-2 domains, despite being separated by 600–800 resi-
dues in the primary sequence. Evidence for a functional linkage
comes from studies of Dock9, where N-terminal fragments
including either the DHR-1 or PH domain bound to DHR-2 in
vitro and affected intrinsic GEF activity (62); and in Dock1, the
N-terminal SH3 domain-autoinhibited GEF activity (82). In
addition, Dock9 forms dimers mediated by its DHR-2 domain
in solution (64) and in crystals (13), and homology modeling of
other Dock family members suggests that they will all form
dimers in the same way (13), consistent with experiments on
Dock1 (64). Moreover, electron micrographs of Dock9 suggest
a compact, dimeric organization for the full-length molecule
(64), indicative of a molecule stabilized by intramolecular and
interdimer interactions.
The FFAS fold-recognition server (87), among others, pre-
dicts significant sequence similarity (confidence level 95%;
supplemental Figs. S9 and S10) for the entire interdomain
region (residues 620–1210) of Dock1 with -importin (PDB
code 2QNA) and other proteins that adopt a HEAT/ARM-re-
peat tertiary fold, a suprahelical structure providing a semicir-
cular scaffold. By aligning helices at the N terminus of the
DHR-2 domain crystal structure with the HEAT/ARM repeats,
and positioning DHR-1 on top of the repeats by analogy with
the organization of PtdIns 3-kinase, the DHR-1 domain is
brought into close apposition with DHR-2 and Rac1 (Fig. 7),
consistent with a structural and functional linkage between
membrane specificity and GEF activity. Themodel further pre-
dicts that themembrane-binding elements ofDHR-1 andRac-1
FIGURE 7. Hypothetical model of the dimeric Dock1-Rac1 membrane
complex. A, the predicted interdomain HEAT/ARM repeats (see also
supplemental Figs. S9 and S10) are shown as orangemolecular surfaces, onto
which DHR-1 (blue ribbon) is modeled by analogywith the structure of PtdIns
3-kinase (84). The DHR2 dimer (green/lime surface) bound to Rac1 (magenta
ribbon) ismodeledon theDock9-Cdc42 complex (13).Membrane attachment
sites for DHR-1 (PtdIns(3,4,5)P3 head group) and Rac-1 (prenylated C termi-
nus) are indicated. B, the same as A but rotated by 90° about a horizontal axis,
providing a “membrane view” of the complex. The region N-terminal to the
DHR-1domain (shownschematically) is predicted to lie adjacent to theDHR-2
domain; it includes the SH3 domain in DockA/B or the PH domain in DockD.
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(and their symmetry mates across the dimer axis) achieve
coplanarity, which would enable simultaneous engagement of
the plasma membrane by four components, enhancing affinity
through avidity effects. A continuation of the ARM-repeat cur-
vature would also bring the SH3 (DockA/B) or PH (DockD)
domains into close apposition with DHR-2, consistent with the
functional studies.
We therefore propose the following scenario of Dock180
function: (i) localization of the Dock180-ELMO complex to the
leading edge is initially promoted by a combination of the rec-
ognition by ELMO of one of its partners and the avidity of
dimeric Dock180 for phospholipids, mediated by its DHR-1
domain, with secondary contributions from its PH domain
(DockD) or C-terminal linear motifs (DockA). (ii) The dimeric
organization and ARM-repeat linkage between the DHR-1
and DHR-2 domains creates a rather rigid complex that can
“land” on (and “take off” from) the membrane, presenting
DHR-2 at an optimal height and orientation to engage Rac1.
(iii) By binding with relatively low affinity, DHR1 can search
for an optimal site by repeatedly sampling the membrane
and/or promoting diffusion of PtdIns(3,4,5)P3 through the
membrane toward Dock180. The probability of encounter-
ing Rac1 is enhanced when DHR-1 finds an elevated concen-
tration of PtdIns(3,4,5)P3, by virtue of an increased mem-
brane retention time and/or the independent co-localization
of Rac1 to the same site. (iv) Once DHR-2 engages GDP-
bound Rac1, it remains bound until GDP is released and GTP
is loaded. (v) The dynamic DHR-1/membrane interaction
then promotes removal of Dock180 from the vicinity of
GTP-loaded Rac1, enabling its effectors to bind, and the
search for the next GDP-bound Rac1 to begin.
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Figure S1.  The surface loops of DHR-1 
 
(A) and (B) Differences between surface loops in 2 independent copies within the DHR-1 crystals. 
Loops  L1 (A) and  L3 (B) are overlaid, with selected side chains shown.  Analogous loops are typically 
poorly ordered in C2 domains, but in DHR-1, L1 (441-444) and L2 (Molecule A: 520-524; and Molecule 
B: 518-524) are connected at the  0.7σ and 0.6σ contour levels in a CNS 2Fo − Fc density map. Residue 
labeling is for the conformation shown in yellow. 
 
 
(C) Simulated-annealing omit map (stereo image) of Molecule A.  Annealing at 1000 K in ‘torsion 
dynamics’ mode was performed with CNS, in which residues K446 and H515 (a 3.5 Å sphere around 
these residues) were omitted from phasing. The 2mFo-DFc map is displayed around the labeled residues 
at a 1.0 σ contour. 
 
 3 
 
Figure S2.  DHR-1 Structural homologs assessed by DALI (Holm et al, 2008).  Top 41 closest 
homologs (unique sequences), ranked by “Z-score”.  Z-scores above 6 are considered ‘highly significant’.  
Columns are:  Rank, PDB code, “Z-score”, RMS difference on Cα for the given number of aligned 
residues (# align). %id = % identity for the aligned residues.   
 
Rank  PDB     Z      RMSD    #align    %id                           PROTEIN  
 
1:  2isd 13.3  2.1   121   12   PHOSPHOINOSITIDE PHOSPHOLIPASE C  
2:  2enq 12.9  2.8   143   10   PtdIns(4,5) 3-KINASE ALPHA   
3:  2qzq 12.9  2.4   129   14   DORSALIZATION ASSOCIATED PROTEIN  
4:  1qas 12.8  2.2   118   12   PHOSPHOLIPASE C DELTA-1   
8:  2nsq 12.7  2.0   119   16   E3 LIGASE NEDD4-LIKE PROTEIN  
9:  1e8x 12.6  2.3   127   12   PtdIns(4,5) 3-KINASE GAMMA  
10: 1cjy 12.4  2.0   115   12   CYTOSOLIC PHOSPHOLIPASE A2   
11: 2nq3 12.3  2.7   119   15   ITCHY HOMOLOG E3 LIGASE  
12: 1rlw 12.3  1.7   112   13   PHOSPHOLIPASE A2  
13: 2cjt 12.0  2.6   117   14   UNC-13 HOMOLOG A  
14: 3jzy 12.0  1.9   111   11   INTERSECTIN 2 
15: 2dmh 11.6  2.2   114   14   MYOFERLIN 
16: 2ep6 11.4  2.0   112   13   MCTP2 
17: 1gmi 10.8  2.5   110    8   PROTEIN KINASE C, EPSILON 
18: 1uov 10.4  2.2   113   14   SYNAPTOTAGMIN I  
19: 2fk9 10.2  2.4   108   11   PROTEIN KINASE C, ETA 
20: 1tjx 10.1  2.4   113   15   SIMILAR TO SYNAPTOTAGMININ/P65 
21: 1dqv 10.0  3.5   111    9   SYNAPTOTAGMIN III 
22: 2dmg  9.8  2.6   116   10   KIAA1228 PROTEIN 
23: 2uzp  9.8  3.0   116    9   PROTEIN KINASE C, GAMMA 
24: 3fdw  9.8  2.6   109   15   SYNAPTOTAGMIN-LIKE PROTEIN 4 
25: 1a25  9.8  2.8   114   10   PROTEIN KINASE C, BETA 
26: 2bwq  9.8  1.9   101   13   RIM2 C2A 
27: 1wfj  9.7  2.6   107   15   PUTATIVE ELICITOR-RESPONSIVE GENE   
28: 2jqz  9.7  2.7   117   14   HSMURF2  
29: 3fbk  9.5  3.6   119   12   REGULATOR OF G-PROTEIN SIGNALING 3;  
30: 2k8m  9.5  2.3   110   13   PUTATIVE UNCHARACTERIZED PROTEIN 
31: 2d8k  9.4  2.5   110   10   SYNAPTOTAGMIN VII  
32: 2k3h  9.4  2.5   107   12   RABPHILIN-3A;  
33: 1w15  9.1  2.1   102   14   SYNAPTOTAGMIN IV;  
34: 2q3x  9.1  2.5   111   11   SYNAPTIC MEMBRANE EXOCYTOSIS REGULATOR  
35: 2z0u  8.9  2.3   104   11   WW DOMAIN-CONTAINING PROTEIN 1  
36: 2yrb  8.7  2.7   120    7   PROTEIN FANTOM;  
37: 2enp  8.3  2.7   110   14   B/K PROTEIN;  
38: 1rh8  7.9  2.7   105   12   PICCOLO PROTEIN  
39: 2enj  7.3  3.0   102   14   PROTEIN KINASE C, THETA  
40: 1wfm  7.1  3.1   106   12   SYNAPTOTAGMIN XIII  
41: 1d5r  7.0  2.7   102   12   PHOSPHOINOSITIDE PHOSPHATASE PTEN 
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Figure S3.  Structural and sequence comparisons between Dock1 DHR-1 domain and 
PtdIns 3-kinase (2ENQ).   
 
A.  Structure-based alignment from DALI, with secondary structure (H=helix; E=strand; L=loop) 
indicated. PtdIns 3-kinase has shorter insertions at the two insertions indicated.  Sequence 
identity is 10%. 
 
                                            β2-β3 loop    
DHR-1 NDIYVTLVQGDFDKGSKSTTAKNVEVTVSVYDEDGKRLEHVIFPGAGDEAISEYKSVIYY 
2ENQ  SALRIKILCATVNVN-IRDIDRIYVRTGIYHGGEPLC-----------DNVNTQRVP--- 
      LEEEEEEEEEELLLLLLLLLLLEEEEEEEEELLLLLLLLLEELLLLLLLLLLEELLLLLL 
 
DHR-1 QVKQPRWFETVKVAIPIEDVNRSHLRFTFRHRSSQDSKDKSEKIFALAFVKLMRYDGTT 
2ENQ  -CSNPRWNEWLNYIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYYDTL 
      LLLLLLLLEEEEEELLLLLHHHEEEEEEEEELLLLLLLLLLLLEEEEEEEELLLLLLLL 
  
                                                                 β7-β8 insertion    
DHR-1 LRDGEHDLIVYKAEAKKLEDAATYLSLPSTKAELEEKSMQSLGSCTISKDSFQISTLVC 
2ENQ  TLV--SGKMALNLWPVGLEDLNPIGVTGSNP-----------------KETPCLEFDWF 
      LLLEEEEELLEELLHHHHLLHHHHLLLLLLHHHHHLLLLLEELLEEELLLEEEEEEEEL 
 
 
B. Structural overlay (stereo).  Superposition of the DHR-1 C2 domain (violet) with the PI 3-
kinase-γ C2 domain (gray).  The HEAT/ARM repeats (magenta) found in the full-length 
structure of PtdIns 3-kinase-γ are also shown.  Note that the helix in the β7-β8 insertion (H3 in 
DHR-1), which mediates extensive interactions with the HEAT/ARM repeats in PtdIns 3-kinase-
γ, is common to both domains  
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Figure S4. ITC titration curves for phosphilipid binding to DHR-1. (A—C) Representative 
ITC profiles: (A) 2 μl injections of 500 μM PtdIns(3,4,5)P3 in 145 mM NaCl titrated into a cell 
containing 35 μM DHR-1. (B) 500 μM PtdIns(4,5)P3 in 14 mM NaCl titrated  into 35 μM DHR-
1.  (C) 500 μM Ins(1,3,4,5)P4 into 25 μM DHR-1 (D) 584 μM PtdIns(4,5)P2 into 35 μM DHR-1. 
(E—F) Competition assays.  (E) 2 μl injections of 500μM PtdIns(3,4,5)P3 titrated into pre-
equilibrated PtdIns(4,5)P2/DHR-1 (35 μM DHR-1 + 1.5-fold molar excess of PtdIns(4,5)P2). (F) 
2 μl injections of 582 μM PtdIns(4,5)P2 titrated into pre-equilibrated PtdIns(3,4,5)P3/DHR-1 (35 
μM DHR-1 + a 1.5-fold molar excess of PtdIns(3,4,5)P3). 
 
 
 6 
Figure S5. Surface electrostatic potentials comparing DHR-1 with other C2 domains. Top 
view looking down onto the surface loops of (A) calcium-independent and (B) calcium-
dependent (left = calcium-free; right = calcium-bound) C2 domains.  Electrostatic potentials 
calculated using APBS (Baker et al, 2001) and contoured at –5 kBT/e- (red) and +5 kBT/e- 
(blue).  PTEN=1D5R; PtdIns3K-C2α=2B3R; Syn I C2A=1BYN; PKC-α= 3GPE. 
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Figure S6. Computational docking of Ins(1,3,4,5)P4 into DHR-1. (A) DHR-1 electrostatic 
surface map and the top 10 Ins(1,3,4,5)P3 solutions as analyzed by ‘Reranking Score’ in Molegro 
Virtual Docker (Thomsen & Christensen, 2006). (B) Stereoview of ‘top-ranked’ PtdIns(3,4,5)P3-
binding mode prediction in the β-groove (note: we found no experimental evidence supporting 
binding at this site). Side chain flexibility was applied during the docking procedure, and 
conformations observed in the crystal structure (white) and after computational docking (green) 
are shown; see Material and Methods for details. A stereo image of Ins(1,3,4,5)P4 docked into 
the upper surface loops is given in the main text (Fig. 5). 
 
 
 
 
 8 
 
Figure S7. PtdIns(3,4,5)P3-binding motifs in the Dock180 family. A detailed view of the L1 
and L3 alignments.  The central red boxes contains residues that may interact with the 
phosphoinositide head-group.  Red-circled residues were mutated and shown to affect binding.  
With the exception of the beginning of L1 (which has an irregular conformation in Dock1), the 
loops show an alternating pattern of basic residues consistent with extended conformations that 
may present the (cyan-boxed) basic residues into the PtdIns(3,4,5)P3 binding pocket.  However, 
experimental verification is clearly required.  Residues boxed in green have sidechains lining the 
β-groove, but mutations at these positions had no effect on phosphoinositide binding.   
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Figure S8. Stereoview of the putative phosphoinositide binding site in the Dock9 PH 
domain. (A) Superposition of the phosphoinositide binding sites of Dock9 (green) with Bruton's 
tyrosine kinase (yellow, PDB=1BWN) and DAPP1/PHISH (orange, PDB=1FAO). (B) 
Electrostatic surface potential of the Dock9 site, with Ins(1,3)P2 modeled into site.  Only the 3-
phosphate is predicted to make strong interactions.  The presence of F215 instead of the tyrosine 
found in other PH domains disfavors binding at the 4-phosphate position, by creating a steric 
clash with K182.  A phosphate at the 5-position is predicted to be tolerated with little energetic 
consequence.  The model is thus consistent with the observed preferences for PtdIns(3)P1 and 
PtdIns(3,5)P2 (Meller et al, 2008). 
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Figure S9. 3D-Jury predictions of an ARM-repeat domain between DHR-1 and DHR-2.  
 
3D-Jury’s top 18 unique hits based on the Dock1 sequence (residues 600–1200) are all ARM-
repeat domains (classified by Families of Structurally Similar Proteins (FSSP) as 11.1.1 and by 
Structural Classification Of Proteins (SCOP) as a.118.1).  The fold predictions accurately 
identify the DHR-1 and DHR-2 domain boundaries.  3DJury produces meta-predictions based on 
several prediction algorithms (3D-PSSM (Kelley et al, 2000), PDB-Basic (Ginalski et al, 2004b), 
FFAS03 (Rychlewski et al, 2000), Fugue (Rychlewski et al, 2000), mGenThreader (Jones, 
1999a) and INUB (Fischer, 2003)), and scores models by their similarity to other models.  
Jscores above 50 indicate correct fold assignment with >90% probability (Ginalski et al, 2004a).  
 
PP2A = Protein Phosphatase 2A; Ap1-β1 = Ap1 Clathrin Adaptor; [N] = Nuclear transport; [E] = 
Endocytosis; [S] = Scaffold protein 
 
Fold Prediction Server Jscore  PDB  Protein  
FFAS03 157 1QGK human importin-β [N] 
INUB 157 1QGK human importin-β [N] 
3D-PSSM 150 1B3U human PP2A-α[S] 
INUB 149 2BKU yeast importin-β [N] 
mGenThreader 147 1QGR human importin-β [N] 
FFAS03 141 2BKU yeast importin-β [N] 
3D-Basic 138 1W63 mouse Ap1-γ [E] 
Fugue 134 1QGR human importin-β [N] 
FFAS03 132 1W63 mouse Ap1-γ [E] 
FFAS03 131 1UKL mouse importin-β [N] 
3D-Basic 127 1W63 mouse Ap1-β1 [E] 
INUB 118 1W63 mouse Ap1-γ [E] 
Fugue 114 1B3U human PP2A-α[S] 
mGenThreader 110 2BKU yeast importin-β [N] 
INUB 109 1B3U human PP2A-α[S] 
INUB 104 1W63 mouse Ap1-β1 [E] 
mGenThreader 100 1B3U human PP2A-α[S] 
FFAS03 98 1OT8 human transportin-1 [N] 
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Figure S10. Secondary structure predictions for the DHR-1/DHR-2 interdomain region of 
Dock1. Predictions by Psipred (Jones, 1999b) and Profsec, an improved PHDsec (Rost, 1996), 
and Jpred3 (Cole et al, 2008), show a high correlation for residues 620 to 1210. The domain 
boundaries for DHR-1 and DHR-2 defined by crystal structures are highlighted in yellow and 
cyan.  H=helix; E=strand; C=coil/loop 
 
 
Dock1   DSFQISTLVCSTKLTQNVDLLGLLKWRSNTSLLQQNLRQLMKVDGGEVVKFLQDTLDALFNIMMENSESE  
Psipred CEEEEEEEEEEEEECCCHHHHHHHHHHCCHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCC  
Profsec CCEEEEEEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCCC  
Jpred3  CEEEEEEEEEEEEEECCCCHHHHHHHCCCCCHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCCC  
 
Dock1   TFDTLVFDALVFIIGLIADRKFQHFNPVLETYIKKHFSATLAYTKLTKVLKNYVDGAEKPGVNEQLYKAM  
Psipred CHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHH  
Profsec HHHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHH  
Jpred3  CCCCHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCEECCHHHHHHHHHHHHHCCCCCCCHHHHHHHH  
 
Dock1   KALESIFKFIVRSRILFNQLYENKGEADFVESLLQLFRSINDMMSSMSDQTVRVKGAALKYLPTIVNDVK  
Psipred HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHH  
Profsec HHHHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH  
Jpred3  HHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH 
 
Dock1   LVFDPKELSKMFTEFILNVPMGLLTIQKLYCLIEIVHSDLFTQHDCREILLPMMTDQLKYHLERQEDLEA  
Psipred HHCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCHHHH  
Profsec HCCCHHHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCHHHHH  
Jpred3  HCCCHHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCHHHH 
 
 
Dock1   CCQLLSHILEVLYRKDVGPTQRHVQIIMEKLLRTVNRTVISMGRDSELIGNFVACMTAILRQMEDYHYAH  
Psipred HHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCHHH  
Profsec HHHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCHHH  
Jpred3  HHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHH 
 
Dock1   LIKTFGKMRTDVVDFLMETFIMFKNLIGKNVYPFDWVIMNMVQNKVFLRAINQYADMLNKKFLDQANFEL  
Psipred HHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCHHHH  
Profsec HHHHHCCCCHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCHHH  
Jpred3  CCCCCCCCCHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCHHH 
 
Dock1   QLWNNYFHLAVAFLTQESLQLENFSSAKRAKILNKYGDMRRQIGFEIRDMWYNLGQHKIKFIPEMVGPIL  
Psipred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCHHHHHHHHHHHHHHHHCCCCHHHHHHHHHHHHH  
Profsec HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCHHHHHHHHHHHHHHHHCCCCCCHHHHHHHHHH  
Jpred3  HHHHHHHHHHHHHHCCCCCECCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCHHHHHH 
 
Dock1   EMTLIPETELRKATIPIFFDMMQCEFHSTRSFQMFENEIITKLDHEVEGGRGDEQYKVLFDKILLEHCRK  
Psipred HHHCCCCHHHHHCCHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHC  
Profsec HEEECCCHHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHCC  
Jpred3  HHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHCCCC 
 
Dock1   HKYLAKTGETFVKLVVRLMERLLDYRTIMHDENKENRMSCTVNVLNFYKEIEREEMYIRYLYKLCDLHKE  
Psipred CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHH  
Profsec CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHC  
Jpred3  CCCCCHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHH 
 12 
 
References 
 
Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA (2001) Electrostatics of nanosystems: 
application to microtubules and the ribosome. Proc Natl Acad Sci U S A 98(18): 10037-10041 
 
Cole C, Barber JD, Barton GJ (2008) The Jpred 3 secondary structure prediction server. Nucleic 
Acids Res 36(Web Server issue): W197-201 
 
Fischer D (2003) 3D-SHOTGUN: a novel, cooperative, fold-recognition meta-predictor. 
Proteins 51(3): 434-441 
 
Ginalski K, Kinch L, Rychlewski L, Grishin NV (2004a) BOF: a novel family of bacterial OB-
fold proteins. FEBS Lett 567(2-3): 297-301 
 
Ginalski K, von Grotthuss M, Grishin NV, Rychlewski L (2004b) Detecting distant homology 
with Meta-BASIC. Nucleic Acids Res 32(Web Server issue): W576-581 
 
Holm L, Kaariainen S, Rosenstrom P, Schenkel A (2008) Searching protein structure databases 
with DaliLite v.3. Bioinformatics 24(23): 2780-2781 
 
Jones DT (1999a) GenTHREADER: an efficient and reliable protein fold recognition method for 
genomic sequences. J Mol Biol 287(4): 797-815 
 
Jones DT (1999b) Protein secondary structure prediction based on position-specific scoring 
matrices. J Mol Biol 292(2): 195-202 
 
Kelley LA, MacCallum RM, Sternberg MJ (2000) Enhanced genome annotation using structural 
profiles in the program 3D-PSSM. J Mol Biol 299(2): 499-520 
 
Meller N, Westbrook MJ, Shannon JD, Guda C, Schwartz MA (2008) Function of the N-
terminus of zizimin1: autoinhibition and membrane targeting. Biochem J 409(2): 525-533 
 
Rost B (1996) PHD: predicting one-dimensional protein structure by profile-based neural 
networks. Methods Enzymol 266: 525-539 
 
Rychlewski L, Jaroszewski L, Li W, Godzik A (2000) Comparison of sequence profiles. 
Strategies for structural predictions using sequence information. Protein Sci 9(2): 232-241 
 
Thomsen R, Christensen MH (2006) MolDock: a new technique for high-accuracy molecular 
docking. J Med Chem 49(11): 3315-3321 
 
 
 
 
 
Liddington
Laurie A. Bankston, Boguslaw Stec, Kristiina Vuori, Jean-Francois Côté and Robert C. 
Lakshmanane Premkumar, Andrey A. Bobkov, Manishha Patel, Lukasz Jaroszewski,
Guanine Exchange Factors (Rho-GEFs)
Structural Basis of Membrane Targeting by the Dock180 Family of Rho Family
doi: 10.1074/jbc.M110.102517 originally published online February 18, 2010
2010, 285:13211-13222.J. Biol. Chem. 
  
 10.1074/jbc.M110.102517Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
Supplemental material:
  
 http://www.jbc.org/content/suppl/2010/02/18/M110.102517.DC1.html
  
 http://www.jbc.org/content/285/17/13211.full.html#ref-list-1
This article cites 87 references, 31 of which can be accessed free at
 at UQ Library on October 6, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
